Sentinel Asset Management’s Haemonetics HAE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q4
Sell
-350,226
Closed -$15.7M 57
2017
Q3
$15.7M Sell
350,226
-10,110
-3% -$420K 0.38% 91
2017
Q2
$14.2M Buy
360,336
+13,205
+4% +$542K 0.34% 108
2017
Q1
$14.1M Buy
347,131
+48,278
+16% +$1.89M 0.33% 93
2016
Q4
$12M Sell
298,853
-103,605
-26% -$3.91M 0.3% 105
2016
Q3
$14.6M Buy
402,458
+27,310
+7% +$938K 0.35% 104
2016
Q2
$10.9M Buy
375,148
+62,668
+20% +$1.89M 0.26% 141
2016
Q1
$10.9M Buy
312,480
+16,100
+5% +$520K 0.24% 131
2015
Q4
$9.55M Sell
296,380
-105,100
-26% -$3.41M 0.24% 133
2015
Q3
$13M Hold
401,480
0.33% 102
2015
Q2
$16.6M Hold
401,480
0.38% 98
2015
Q1
$18M Sell
401,480
-18,700
-4% -$782K 0.39% 96
2014
Q4
$15.7M Buy
420,180
+53,170
+14% +$1.95M 0.33% 114
2014
Q3
$12.8M Hold
367,010
0.27% 147
2014
Q2
$12.9M Buy
367,010
+1,070
+0.3% +$35.7K 0.26% 152
2014
Q1
$11.9M Buy
365,940
+1,550
+0.4% +$59.2K 0.24% 171
2013
Q4
$15.4M Sell
364,390
-17,700
-5% -$728K 0.3% 138
2013
Q3
$15.2M Buy
382,090
+15,130
+4% +$635K 0.32% 139
2013
Q2
$15.2M Buy
+366,960
New +$14.9M 0.33% 142

Other funds holding HAE